Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA(2)), UCM-14216, Ameliorates Spinal Cord Injury in Mice Publications, Year: 2022, Type: ArticleGwen KaeserAugust 10, 2022LPA Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes